Development and validation of an artificial intelligence PIVKA-II-based model for the prediction of hepatocellular carcinoma development in patients with HCV-related cirrhosis successfully treated with direct-acting antivirals

被引：0
|
作者：
Caviglia, G. P. [1 ]
Fariselli, P. [2 ]
D'Ambrosio, R. [3 ]
Degasperi, E. [3 ]
Troshina, G. [1 ]
Nicolosi, A. [1 ]
Saracco, G. M. [1 ,4 ]
Lampertico, P. [3 ,5 ]
Ciancio, A. [1 ,4 ]
机构：
[1] Univ Turin, Dept Med Sci, Liver Unit, Turin, Italy
[2] Univ Turin, Dept Med Sci, Computat Biomed, Turin, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[4] Citta Salute & Sci Torino Molinette Hosp, Gastroenterol Unit, Turin, Italy
[5] Univ Milan, Dept Pathophysiol & Transplantat, CRC AM & Migliavacca Ctr Liver Dis, Milan, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2022年 / 54卷
关键词：
D O I：
10.1016/j.dld.2022.08.002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC-01
引用
收藏
页码：S165 / S165
页数：1
相关论文
共 50 条
  • [31] Adherence to hepatocellular carcinoma screening in patients with hepatitis C cirrhosis treated with direct-acting antivirals against hepatitis C
    Suarez Zambrano, Elisaul
    Acosta-Lopez, Silvia
    Diaz Bethencourt, Dacil
    Soledad Garrido, Maria
    Suarez Darias, Ruth
    Perez Hernandez, Francisco Andres
    JOURNAL OF HEPATOLOGY, 2022, 77 : S931 - S931
  • [32] Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals
    Ogawa, Eiichi
    Nomura, Hideyuki
    Nakamuta, Makoto
    Furusyo, Norihiro
    Kajiwara, Eiji
    Dohmen, Kazufumi
    Kawano, Akira
    Ooho, Aritsune
    Azuma, Koichi
    Takahashi, Kazuhiro
    Satoh, Takeaki
    Koyanagi, Toshimasa
    Ichiki, Yasunori
    Kuniyoshi, Masami
    Yanagita, Kimihiko
    Amagase, Hiromasa
    Morita, Chie
    Sugimoto, Rie
    Kato, Masaki
    Shimoda, Shinji
    Hayashi, Jun
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (03) : 431 - 440
  • [33] Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals
    Ahmed Mohamed ElGhandour
    Essam Mohamed Bayoumy
    Wesam Ahmed Ibrahim
    Moataz Mohamed Sayed
    Ashraf Bekheet Salama
    Nahla Mohamed Teama
    Mohamed Magdy Salama
    Egyptian Liver Journal, 11
  • [34] Risk factors of development of hepatocellular carcinoma in HCV patients after direct-acting antiviral therapy
    Morimoto, Naoki
    Isoda, Norio
    Miura, Kouichi
    Watanabe, Shunji
    Takaoka, Yoshinari
    Tsukui, Mamiko
    Murayama, Kozue
    Hirosawa, Takuya
    Yamamoto, Hironori
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 156 - 156
  • [35] Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals
    ElGhandour, Ahmed Mohamed
    Bayoumy, Essam Mohamed
    Ibrahim, Wesam Ahmed
    Sayed, Moataz Mohamed
    Salama, Ashraf Bekheet
    Teama, Nahla Mohamed
    Salama, Mohamed Magdy
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [36] Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals
    Calvaruso, V.
    Cabibbo, G.
    Cacciola, I.
    Petta, S.
    Madonia, S.
    Bellia, A.
    Stefano, M. D.
    Giannitrapani, L.
    Tine, F.
    Magro, A.
    Davi, A.
    Larocca, L.
    Ardiri, A.
    Digiacomo, A.
    Gussio, M.
    Guarneri, L.
    Scalisi, I.
    Mazzola, G.
    Cartabellotta, F.
    Savalli, F.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Camma, C.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S23 - S24
  • [37] Hepatocellular carcinoma incidence in patients with advanced fibrosis or cirrhosis treated for hepatitis C with direct-acting antivirals in a single Australian center
    Chan, P. P. Y.
    Navani, V.
    Ladera, A.
    Coppock, J.
    Shackel, N.
    Levy, M. T.
    Davison, S.
    Prakoso, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 38 - 39
  • [38] Correlation Between Vascular Endothelial Growth Factor and Long-Term Occurrence of HCV-Related Hepatocellular Carcinoma After Treatment with Direct-Acting Antivirals
    Ramadan, Haidi K.
    Meghezel, El-Zahraa M.
    Abdel-Malek, Mohammed O.
    Askar, Ashraf A.
    Hetta, Helal F.
    Mahmoud, Amal A.
    Abdel-Aal, Amal M.
    CANCER INVESTIGATION, 2021, 39 (08) : 653 - 660
  • [39] Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case-control study
    Adhoute, Xavier
    Penaranda, Guillaume
    Raoul, Jean Luc
    Sellier, Floriane
    Castellani, Paul
    Oules, Valerie
    Perrier, Herve
    Lefolgoc, Gaelle
    Pol, Bernard
    Campanile, Manuela
    Bayle, Olivier
    Beaurain, Patrick
    Monnet, Olivier
    Bourliere, Marc
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (04) : 368 - 375
  • [40] Editorial: the role for PIVKA-II measurement after HCV elimination by direct-acting anti-virals in terms of prediction of hepatocellular carcinoma
    Ogawa, Eiichi
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (01) : 122 - 123
12345